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Mitochondria have been suggested as a potential target for cytoprotective strategies. It has been shown that increased K+ uptake mediate 
by mitochondrial ATP-regulated potassium channels (mitoKATP channel) or large-conductance Ca2+-activated potassium channels (mitoBKCa 
channel) may provide protection in different models of cell death. Since recent findings demonstrated the presence of BKCa channels in 
neuronal mitochondria, the goal of the present study was to test the potential neuroprotective effects of BKCa channel modulators. Using 
organotypic hippocampal slice cultures exposed to glutamate, we demonstrated that preincubation of the slices with the BKCa channel 
opener NS1619 resulted in decreased neuronal cell death measured as reduced uptake of propidium iodide. This neuroprotective effect 
was reversed by preincubation with the BKCa channel inhibitors paxilline and Iberiotoxin (IbTx). Moreover, mitochondrial respiration 
measurements revealed that NS1619 induced an IbTx-sensitive increase in state 2 respiration of isolated brain mitochondria. In addition, 
electrophysiological patch-clamp studies confirmed the presence of BKCa channels in mitoplasts isolated from embryonic hippocampal 
cells. Taken together, our results confirm presence of BKCa channel in rat hippocampal neurons mitochondria and suggest putative role 
for mitoBKCa in neuroprotection.
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INTRODUCTION
Mitochondria, the key regulators of cellular metabolism, 
are involved in ATP synthesis and the accumulation of 
cytoplasm calcium ions, as well as in reactive oxygen species 
(ROS) synthesis (Feissner et al. 2009). It is also known that 
mitochondria play a central role in the initiation of the 
intrinsic apoptotic signaling cascade. This dual function 
makes mitochondria particularly interesting in the context 
of cytoprotective strategies (Halestrap et al. 2007, Busija et 
al. 2008, Murphy and Steenbergen 2007). Potential targets 
for neuroprotective intervention include the permeability 
transition pore (PTP) and uncoupling proteins. In addition, 
recent studies have implicated mitochondrial potassium 
channels in the mechanism of preconditioning, a promising 
approach for cytoprotection (Facundo et al. 2006, Szewczyk 
et al. 2009, 2010, Szabo and Zoratti 2014).
A growing body of evidence has demonstrated that 
ischemic preconditioning, a phenomenon in which brief 
episodes of ischemia increase tissue tolerance to subsequent 
lethal insult, could be mimicked by administration of 
potassium channel openers (KCOs) (O’Rourke 2007). In 
contrast to the initial understanding of plasma membrane 
potassium channels as major mediators of preconditioning, 
it is now thought that the primary cytoprotective effects 
are derived from potassium channels in the inner 
mitochondrial membrane (Szewczyk and Marban 1999, 
O’Rourke 2007). Increased potassium transport into brain 
mitochondria catalyzed by mitochondrial ATP-regulated 
potassium channels (mitoKATP channels) has been shown 
to affect mitochondrial membrane potential and the rate 
of respiration, leading to subsequent beneficial effects on 
neuronal survival (Rodriguez-Pallares et al. 2009, Watanabe 
et al. 2008, Gaspar et al. 2008a, Raval et al. 2007). In addition, 
recent research targeted mitochondrial large-conductance 
Ca2+-regulated potassium channels (mitoBKCa channel) for 
cardioprotective strategies (Xu et al. 2002).
Large-conductance Ca2+-activated potassium channels 
(BKCa) were originally identified in the plasma membranes of 
smooth muscle cells, neurons and chromaffin cells as well as in 
the kidney and inner ear (Grimm and Sansom 2007, Eichhorn 
and Dobrev 2007). Due to their sensitivity to changes in both 
membrane potential and calcium ions, BKCa channels were © 
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found to be crucial for processes such as neurotransmitter 
release, cell excitability and smooth muscle tone (Latorre and 
Brauchi 2006, Facler and Adelman 2008).
Further studies revealed that BKCa channels are also 
present in mitochondria (Siemen et al. 1999, Xu et al. 
2002). The activity of the putative mitochondrial BKCa 
channel (mitoBKCa), thought to be stimulated by Ca2+ 
and blocked by charybdotoxin, was initially detected in 
mitoplasts from a glioma cell line (Siemen et al. 1999). 
Later, similar single-channel recordings were performed 
for the inner membranes of heart, skeletal muscle, brain 
and endothelium mitochondria (Xu et al. 2002, Skalska 
et al. 2008, 2009, Douglas et al. 2006, Fahnik-Babaei et al. 
2011, Bednarczyk et al. 2013a). The BKCa channel opener 
NS1619 was found to increase K+ influx of intact heart 
mitochondria in a way that was sensitive to BKCa channel 
blockers, charybdotoxin and Iberiotoxin (Xu et al. 2002). 
Furthermore, it has been reported that pharmacological 
preconditioning using NS1619 led to heart protection 
against infarction (Xu et al. 2002). The mechanism of this 
process seems to be partially related to the reduced driving 
force for mitochondrial Ca2+ influx or to superoxide radical 
synthesis (Sato et al. 2005, Kulawiak et al. 2008). In last 
time, it was shown that substrates of the respiratory chain 
can decrease the activity of the mitoBKCa channel and the 
effect is abolished by inhibitors of the respiratory chain. 
The putative interaction of the β4 subunit of mitoBKCa 
with cytochrome c oxidase was demonstrated using blue 
native electrophoresis. These findings indicate functional 
and structural coupling of the mitoBKCa channel with the 
mitochondrial respiratory chain in human astrocytoma 
U-87 MG cells (Bednarczyk at al. 2013b).
Evidence was found for the expression of BKCa 
α and β4 subunits in the inner membrane of neuronal 
mitochondria (Piwonska et al. 2008). The identification 
of BKCa channels in brain mitochondria led to speculation 
about the potential role of this channel in neuroprotection. 
Thus, the goal of the present study was to investigate the 
effects of BKCa channel modulators on neuronal damage 
in organotypic hippocampal slice cultures exposed to 
glutamate.
METHODS
Organotypic hippocampal cultures
Oraganotypic hippocampal slice cultures (OHC) were 
prepared from 7- to 9-day-old Wistar rats (P7-9) using a 
modification of the interface method previously described 
(Stoppini et al. 1991). After decapitation, the brain was 
removed, the hippocampi were dissected and 350 μm thick 
transverse sections were cut on a McIlwain tissue chopper 
(The Mickle Laboratory Engineering, Guildford, UK). The 
slices were carefully separated and transferred to sterile, 
0.4 μm porous Millicell membranes (Millipore, Molsheim, 
France) placed in 6-well plates containing serum-based 
medium [74% culture medium (HME03; Cell Concept GmbH, 
Umkirch, Germany), 0.5% L-glutamine (Biochrom, Berlin, 
Germany), 0.5% gentamycin (Biochrom), 25% horse serum 
(Gibco, Eggenstein, Germany)]. For the following 3 days, the 
cultures were maintained at 37°C in 5% CO2, with a medium 
change performed on the first day in vitro (DIV). Thereafter, 
cultures were transferred to serum-free medium [74% 
culture medium (HME03; Cell Concept GmbH), 0.5% 
L-glutamine (Biochrom), 0.5% gentamycin (Biochrom), 25% 
Neurobasal-A (Gibco) with B27 supplement (Gibco)] and 
were kept in a humidified incubator at 33°C in 5% CO2 with 
the medium changed three times per week.
Slice cultures were used for experiments after 12 DIV. 
Before the experiment, the slices were stained with 
propidium iodide (PI) (2 μM; Sigma, Deißenhofen, Germany) 
to exclude damaged cultures. PI was added to the culture 
medium for 12 h, and PI-negative OHCs were selected using 
a fluorescence microscope (Eclipse TE 300, Nikon, Japan).
Glutamate excitotoxicity
Glutamate excitotoxicity was assessed by 45-minute 
exposure of the slices to 15 mM glutamate (Sigma) at 37°C 
followed by 23-hour incubation in glutamate-free medium 
(serum-free medium) at 33°C. Control cultures were 
maintained for the same time interval at 37°C in serum-
free medium and then returned to their original culture 
conditions at 33°C for the next 23 h.
Pharmacological treatment
Contribution of NMDA receptor activation to glutamate-
-induced neuronal death was tested using the glutamate 
receptor antagonist (5R, 10S)-(+)-5-methyl-10,11-dihydro-
-5H-dibenzo{a, d}cyclohepten-5,10-imine hydrogen maleate 
(MK-801; 10 μM; Tocris, USA). MK-801 was applied 2 h before 
excitotoxicity induction and remained in the medium (see 
Organotypic hippocampal cultures) during the insult and 
after glutamate withdrawal.
To test the effects of BKCa channel modulators on 
the viability of slices exposed to glutamate, the BKCa 
channel activator NS1619 (10 nM–30 μM; Sigma) as 
well as BKCa channel inhibitors paxilline (Pax) (2 μM; 
Tocris) and Iberiotoxin (IbTx) (100 nM; Alomone Labs, 
Israel) were used. The compounds were applied 2 h 
before glutamate exposure, and they remained in the 
medium (see Organotypic hippocampal cultures) during 
the insult and after glutamate withdrawal. Because 
NS1619 and paxilline were pre-dissolved in DMSO (final 
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concentration 0.01%), an additional group of slices 
treated with DMSO alone was included.
In the experiments investigating the temporal profile 
of the effects induced by NS1619 and paxilline, test agents 
were applied to the cultures for 2 h prior glutamate 
exposure, for 45-min co-incubation with glutamate or for 
23 h just after glutamate withdrawal.
Quantification of neuronal death
Neuronal damage was evaluated by cellular uptake of PI. 
At 22 h after glutamate application, PI (10 μM) was added to 
the medium for 2 h at 33°C. For detection of PI fluorescence, 
slices were excited with light at 510–560 nm, and the 
emitted signal was acquired at 610 nm using an inverted 
fluorescence microscope (Eclipse TE 300; Nikon, Japan). 
Fluorescent and transmission images were captured using 
a CCD camera (Visitron Systems, Puchheim, Germany) and 
were analyzed using LUCIA image analysis software (Nikon, 
Japan). The area of analysis for each culture was determined 
based on transmission images. The neuronal damage 
was quantified as the percentage of CA1-CA3 subfields 
expressing PI fluorescence above the background level and 
was calculated in relation to the total slice area. The value 
obtained for slices exposed to glutamate alone was defined 
as the standard damage and normalized to 100% damage. 
All other data are given as the percentage of standard 
damage. Normalized values of neuronal cell death obtained 
from at least three independent experiments are given as 
mean ±SEM. The Mann-Whitney U test was used to compare 
neuronal damage of OHCs treated with BKCa channel 
modulators to the standard damage (100% damage).
Immunostaining of rat brain sections
For immunohistochemical studies, adult male Wistar 
rats (150–200 g) were transcardially perfused with 4% 
paraformaldehyde (PFA). The brains were removed, 
immersed in the same fixative for 24 h and then washed 
in phosphate buffered saline (PBS). Then, the tissue was 
processed for paraffin embedding. Paraffin-embedded 
coronal 4-μm thick sections were dewaxed, rehydrated 
and incubated with 3% hydrogen peroxide for 30 min. For 
antigen retrieval, the sections were heated in a microwave 
oven in citrate buffer (pH 6.0) for 2×7 min. Nonspecific 
antibody binding sites were blocked by preincubating the 
sections with 5% normal donkey serum (NDS) diluted in 
PBS for 30 min. For the simultaneous detection of the BKCa 
β4 subunit and the neuronal marker microtubule associated 
protein 2 (MAP2), sections were incubated overnight at 4°C 
in 5% NDS containing rabbit polyclonal anti-BKCa β4 subunit 
(KCNMB4) antibody (1:50 dilution, Alomone Labs) and mouse 
monoclonal anti-MAP2 antibody (1:100 dilution, Chemicon). 
The immunoreactivity was visualized using AlexaFluor 
488-conjugated donkey anti-mouse antibody and AlexaFluor 
555-conjugated donkey anti-rabbit antibody (Molecular 
Probes). The sections were then mounted in VECTASHIELD 
HardSet Mounting Medium with DAPI (Vector). Confocal 
images were acquired using a Leica TCS SP2 microscope 
with Ar (488 nm) and GeNe (543 nm) lasers applied to the 
excitation of AlexaFluor 488 and AlexaFluor 555, respectively. 
To avoid cross-talk between the two fluorophores, special 
care was taken to adjust detector settings, and the images 
were sequentially scanned.
Isolation of rat brain mitochondria
Rat brain mitochondria were prepared according to 
a standard protocol. In brief, each male Wistar rat was 
anesthetized with chloroform and then sacrificed by cervical 
dislocation. The brain was rapidly removed, washed and placed 
in ice-cold buffer containing 225 mM mannitol, 75 mM sucrose, 
5 mM HEPES, BSA (1 mg/ml), 1 mM EGTA, pH 7.4. The tissue was 
then minced with scissors, placed in 10 ml of isolation medium 
supplemented with nagarse (0.5 mg/ml) and then homogenized 
using a motor-driven Teflon-glass Potter homogenizer. The 
homogenate was diluted two times. After then, the homogenate 
was centrifuged at 2,000 g for 9 min. The supernatant was 
decanted and centrifuged at 12,000 g for 11 min. To permeabilize 
synaptosomes, the pellet was suspended in an isolation buffer 
supplemented with digitonin (0.2 mg/ml) and homogenized 
manually. Finally, the suspension was centrifuged at 12,000 g 
for 11 min. The crude mitochondrial pellet was resuspended in 
isolation medium at a protein concentration of 20–40 mg/ml. 
All procedures were carried out at 4°C.
Mitochondrial respiration
Mitochondrial oxygen consumption was measured at 
25°C using Oroboros oxygraph (Anton Paar, Austria) in a 
medium containing 10 mM KH2PO4, 60 mM KCl, 60 mM Tris, 
110 mM mannitol and 0.5 mM EDTA at pH 7.4. For each 
measurement, 12 μl of mitochondrial suspension was added 
to 2.1 ml of medium supplemented with 5 mM MgCl2 and the 
respiratory substrates (5 mM malate and 10 mM glutamate). 
State 3 respiration was induced by the addition of 2 mM ADP.
Preparation of mitochondria from embryonic rat 
hippocampal neurons
Pregnant female Wistar rats (18–20 days of pregnancy) 
were euthanized using CO2. Embryos were removed from the 
uterus and decapitated. The brains were dissected out and 
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placed in cold Hank’s balanced salt solution medium (HBSS) 
supplemented with 1 mM HEPES (Sigma-Aldrich, St. Louis, 
MO, USA) and penicillin/streptomycin solution (Invitrogen, 
Paisley, UK). After isolation of hippocampi under a dissecting 
microscope, the tissue was rinsed with cold HBSS and 
digested at 37°C in HBSS medium supplemented with 
0.2% trypsin (Invitrogen) for 15 min. The trypsin solution 
was gently pipetted off, the tissue was rinsed with warm 
HBSS and the cells were dissociated by trituration. After 
sedimentation of non-dispersed tissue, the supernatant was 
transferred to an Eppendorf tube and centrifuged at 5,000 g 
for 10 min. The pellet was resuspended in a preparation 
buffer containing 250 mM sucrose and 5 mM HEPES at pH 
7.2 and homogenized using a glass-glass homogenizer. Then, 
to remove synaptosomes, the resultant homogenate was 
centrifuged at 9,200 g for 10 min. The pellet was resuspended 
in preparation buffer and centrifuged at 790 g for 10 min. 
Next, the supernatant containing purified mitochondria was 
centrifuged at 9,200 g for 10 min and the resultant pellet 
was resuspended in storage buffer containing 150 mM KCl 
and 10 mM HEPES at pH 7.2 centrifuged again under the 
same conditions. The final mitochondrial pellet (crude) was 
resuspended in 500 μl of isotonic solution containing 150 mM 
KCl, 10 mM HEPES, 100 μM CaCl2, pH 7.2. All procedures were 
carried out at 4°C (Bednarczyk et al. 2010).
Patch-clamp experiments
Patch-clamp experiments were carried out essentially 
as previously described (Cheng et al. 2008, Bednarczyk et al. 
2010). In brief, mitoplasts were prepared from mitochondria 
isolated from embryonic rat hippocampal neurons. To 
induce mitochondrial swelling and rupture of the outer 
membrane, samples of the mitochondrial suspension were 
transferred into a hypotonic solution containing 5 mM 
HEPES and 100 μM CaCl2 at pH 7.2 for about 1 min. Then, 
addition of a hypertonic solution that consisted of 750 mM 
KCl, 30 mM HEPES and 100 μM CaCl2 restored isotonicity.
The patch-clamp pipette was filled with an isotonic 
solution containing 150 mM KCl, 10 mM HEPES, and 100 μM 
CaCl2 at pH 7.2. To apply substances to the ion channels 
present in the patch we used the method of back-filling. 
The calcium dependence of the channel activity was 
analyzed using a low calcium solution containing 150 mM 
KCl, 10 mM HEPES, 1 mM EGTA, and 0.752 mM CaCl2 at pH 
7.2. The sensitivity of the single-channel current to the 
BKCa channel inhibitor was tested using 10 μM paxilline. 
Isotonic solution was used as a control solution.
The single-channel currents were recorded using an 
Axopatch 200B amplifier (Molecular Devices, USA). The 
currents were low-pass filtered at 1 kHz and sampled 
at a frequency of 100 kHz using Clampex 10 software 
(Molecular Devices, USA). Recording was performed in 
mitoplast-attached mode using a pipette of borosilicate 
glass (Harvard Apparatus, UK) pulled by a Flaming/Brown 
Micropipette Puller (P-97, Sutter Instruments, USA) with a 
resistance of 10–20 MΩ measured in the isotonic solution.
Collected data were analyzed using Clampfit 10 software 
(Molecular Devices, USA). The channel recordings 
illustrated in the results section are representative of 
the most frequently observed conductance under the 
given conditions. The conductance was calculated from 
the current-voltage relationship. The open probability 
as well as the mean time of channel closure and opening 
was determined using the single-channel search mode of 
the Clampfit 10 software. Data from the experiments are 
reported as mean value ±SD.
RESULTS
Effects of BKCa channel modulators on neuronal 
cell death induced by glutamate in organotypic 
hippocampal slice cultures
A 45-min exposure of hippocampal slice cultures to 
15 mM glutamate resulted in pronounced cell death in the 
neuronal cell layers as assessed by propidium iodide uptake 
(Fig. 1A). Basal PI fluorescence was very low (Fig. 1A; control) 
but increased significantly 24 h after the insult (Fig. 1A; Glu). 
Application of the NMDA receptor blocker (10 μM MK-801) 
resulted in decreased PI uptake (Fig. 1A; MK-801) and reduced 
neuronal cell death by 80.9±2% (n=50) (Fig. 1B; MK-801).
Concentration-dependent effects of the BKCa 
channel opener NS1619 on the viability of 
hippocampal slices exposed to glutamate
To test whether BKCa channel openers could modulate the 
effects of glutamate, we applied NS1619 in a concentration 
range that varied from 10 nM to 30 μM. Using an experimental 
protocol with 2-h pre-exposure of the slices to NS1619 followed 
by 45-min incubation with 15 mM glutamate in the presence 
of NS1619 and its subsequent application after glutamate 
withdrawal (Fig. 1C), we found a neuroprotective effect for the 
BKCa channel opener. This effect was observed for high drug 
concentrations and was particularly pronounced at 10 μM 
NS1619 (Fig. 1D). As depicted in Fig. 1D, slice cultures exposed 
to glutamate in the presence of 10 μM NS1619 showed 49.7±5% 
(n=20) reduction in neuronal cell death as compared to 
cultures exposed to glutamate alone. Statistically significant 
decreases in neuronal damage were also detected at 30 μM and 
100 nM NS1619. At these concentrations, neuronal cell death 
was reduced by 43.7±1% (n=8) and 36.3±4% (n=19), respectively 
(Fig. 1D). Application of 1 mM and 10 nM NS1619 did not 
significantly affect culture viability (Fig. 1D).
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Fig. 1. Effects of BKCa channel modulators on glutamate excitotoxicity induced in hippocampal organotypic slice cultures. (A) Representative 
transmission and fluorescent light images of organotypic hippocampal (OHC) slice cultures under control and excitotoxic conditions. OHCs 
prepared from P7–9 rats were cultivated for 12 DIV and, after selection with PI, were exposed for 45 min to 15 mM Glu. MK-801 was used 
as a positive control for neuroprotection. OHCs were treated with MK-801 (10 μM) for 2 h before, during and 24 h after glutamate exposure. 
(B) Statistical analysis of neuronal damage measured as PI uptake in control cultures (Control), or in cultures exposed to glutamate alone (Glu) 
or in combination with the NMDA receptor antagonist MK-801 (MK-801). The data are expressed as the mean ±SEM; ***P<0.001 vs. glutamate 
(Mann-Whitney U-test). (C) Experimental protocol of OHC treatment with BKCa channel modulators under excitotoxic conditions. 12 DIV PI-negative 
OHCs were treated with the BKCa channel activator NS1619 (10 nM–30 μM) or inhibitors paxilline (Pax; 2 μM) or Iberiotoxin (IbTx; 100 nM) for 
2 h before, during and 23 h after glutamate exposure. (D) Concentration-dependent effects of BKCa channel opener NS1619 on the viability of 
OHCs exposed to glutamate. The most pronounced neuroprotective effect of NS1619 was observed at 10 μM. The data are expressed as the 
means ±SEM of three independent experiments; ***P<0.001, *P<0.1 vs. glutamate (Mann-Whitney U-test). Experimental media (Veh) were used 
as described in Methods sections (Organotypic hippocampal cultures and Pharmacological treatments). (E) Effects of BKCa channel inhibitors on 
neuronal cell death induced by glutamate. Quantification of neuronal damage showed neuroprotective effects of BKCa channel blockers paxilline 
(Pax; 2 μM) and Iberiotoxin (IbTx; 100 nM). The data are expressed as the means ±SEM of three independent experiments; ***P<0.0001, **P<0.01 
vs. glutamate (Mann-Whitney U-test). Experimental media (Veh) were used as described in Methods sections (Organotypic hippocampal cultures 
and Pharmacological treatments).
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Effects of BKCa channel inhibitors on neuronal cell 
death induced by glutamate
Next, we tested the effects of BKCa channel inhibitors on 
glutamate-induced neuronal damage. Paxilline (Pax; 2 μM) and 
Iberiotoxin (IbTx; 100 nM) were applied to the medium 2 h before, 
during and 23 h after glutamate exposure (Fig. 1C). As shown 
in Fig. 1E, BKCa channel blockers were effective for promoting 
neuroprotection against glutamate-induced excitotoxicity. The 
PI uptake measurements showed that addition of 2 μM Pax 
reduced neuronal cell death by 49.3±4% (n=11), whereas 100 nM 
IbTx decreased the cellular damage by 64±4% (n=6) (Fig. 1E).
Temporal profile of neuroprotective effects 
induced by BKCa channel modulators NS1619 and 
paxilline
In the next step, to determine the application time window 
crucial for the effects observed for NS1619 and Pax, cultures 
were preincubated with test agent for 2 h before glutamate 
exposure (Fig. 2A), co-treated with the compound together with 
glutamate for 45 min (Fig. 2B), or incubated with the compound 
for 23 h after glutamate withdrawal (Fig. 2C). As shown in 
Fig. 2D, the 10 μM concentration of NS1619 was neuroprotective 
when applied for 2 h before the insult. Preincubation with 
NS1619 resulted in a 72±4% (n=21) reduction in neuronal cell 
death (Fig. 2D; NS1619 before). In contrast, NS1619 did not affect 
neuronal viability when it was present during the incubation 
with glutamate or when it was applied after the insult. In both 
conditions, do not observed statistically significant changes in 
neuronal damage (Fig. 2D; NS1619 during, NS1619 after).
Analysis of PI fluorescence in slices treated with 
2 μM paxilline demonstrated that the most pronounced 
cytoprotective effect was elicited by co-exposure of the cultures 
to Pax together with glutamate. The presence of the BKCa 
channel blocker during the insult resulted in a 75.3±4% (n=17) 
decrease in neuronal death (Fig. 2D; Pax during). Moreover, 
as shown in Fig. 2D, a less pronounced but still statistically 
significant decrease in slice damage was also found in cultures 
pretreated with Pax (45.1±9%; n=16; Pax before). However, since 
the slices were not washed after the removal of the compound, 
it seems plausible that this effect may result from the residual 
presence of Pax during the incubation with glutamate. The 
significant neuroprotective effect was no longer observed 
when the cultures were subjected to Pax in the recovery period 
after glutamate withdrawal (Fig. 2D; Pax after).
Modulation of NS1619-induced neuroprotection by 
BKCa channel inhibitors
Next, to determine the contribution of BKCa channel 
activation to neuroprotection induced by NS1619, we 
tested whether these effects could be modulated by 
BKCa channel inhibitors. Having established the drug 
application time windows crucial for the neuroprotective 
effects of the BKCa channel activator and inhibitors, we 
concentrated on the NS1619-important pretreatment 
Fig. 2. Temporal profile of neuroprotective effects of BKCa channel 
modulators NS1619 and paxilline on neuronal damage induced by 
glutamate. (A–C) Experimental protocols presenting the time windows of 
BKCa channel modulator application under excitotoxic conditions. 12 DIV 
PI-negative OHCs were treated with NS1619 (10 μM) or paxilline (2 μM) for 
2 h before excitotoxicity induction (A), during 45-min glutamate exposure 
(B) or for 23 h after glutamate withdrawal (C). (D) Statistical analysis of 
time-dependent effects of BKCa channel modulators on neuronal viability in 
OHCs exposed to glutamate. Quantification of neuronal damage showed 
neuroprotective effects of BKCa channel activator NS1619 when applied for 
2 h before glutamate exposure (NS1619 before). The most pronounced 
cytoprotective effect of the BKCa channel inhibitor was observed in cultures 
exposed to paxilline in the presence of glutamate (Pax during). The data 
are expressed as the means ±SEM of three independent experiments; 
***P<0.001, *P<0.1 vs. glutamate (Mann-Whitney U-test). NS1619 before, 
Pax before: cultures were exposed to BKCa channel modulators according 
to protocol A (2 h before glutamate exposure); NS1619 during, Pax during: 
cultures were exposed to BKCa channel modulators according to protocol 
B (during glutamate exposure); NS1619 after, Pax after: cultures were 
incubated with BKCa channel modulators according to protocol C (for 
23  h after glutamate withdrawal). Experimental media (Veh) were used 
as described in Methods sections (Organotypic hippocampal cultures and 
Pharmacological treatments).
2_695_Piwońska_v4.indd   25 18/04/16   21:07
26  M. Piwońska et al. Acta Neurobiol Exp 2016, 76: 20–31
phase for the following experiments. We co-treated 
the cultures with NS1619 and Pax or IbTx for 2 h before 
glutamate exposure. Using the protocol presented in 
Fig. 3A, we were able to exclude the neuroprotective 
effects elicited by BKCa channel inhibitors when co-
applied with glutamate. We found that pretreatment 
of the slices with 10 μM NS1619 resulted in a 72.5±4% 
(n=17) reduction in neuronal cell death when compared 
to the cultures exposed to glutamate alone (Fig. 3B; 
NS1619). Co-application of 10 μM NS1619 together with 
2 μM Pax significantly decreased the neuroprotective 
effect of NS1619 alone, resulting in approximately 
52.7±6% (n=18) neuronal damage (Fig. 3B; NS1619/Pax). 
As shown in Fig. 3B, the complete reversal of NS1619-
induced neuroprotection was assessed using 100 nM 
IbTx. PI uptake measurements showed that the BKCa 
channel activator applied in combination with IbTx 
non-significantly decreased neuronal damage to 85.2±6% 
(n=15) (Fig. 3B; NS1619/IbTx).
Effects of mitoKATP channel modulators on neuronal 
cell death induced by glutamate in organotypic 
hippocampal slice cultures
To test the hypothesis that mitochondrial potassium 
influx plays a role in neuroprotection, we tested whether 
the activation of another mitochondrial potassium 
channel, the mitoKATP channel, leads to the similar effects. 
We pre-treated cultures with 30 μM BMS191095, which is a 
specific activator of the mitoKATP channel (Fig. 4A) (Grover 
et al. 2001). Analysis of PI fluorescence demonstrated 
that BMS191095 reduced neuronal damage by 73±4% 
(n=17) (Fig. 4B; BMS191095); this was very similar to the 
effects induced by NS1619. Moreover, 5-HD, an inhibitor 
of the mitoKATP channel (Hu et al. 1999), abolished the 
neuroprotection elicited by BMS191095. As presented 
in Fig. 4B, co-application of these compounds together 
resulted in a statistically non-significant 94.1±6% (n=16) 
decrease in cellular cell death (Fig.4B; BMS191095/5-HD).
Fig. 3. Modulation of NS1619-induced neuroprotection by BKCa channel 
inhibitors. (A) Experimental protocol presenting the time window of 
BKCa channel modulator application under excitotoxic conditions. 12 DIV 
PI-negative OHCs were treated with NS1619 (10 μM) together with paxilline 
(Pax; 2 μM) or Iberiotoxin (IbTx; 100 nM) for 2 h before excitotoxicity 
induction. (B) Statistical analysis of the effects elicited by BKCa channel 
inhibitors on NS1619-induced neuroprotection. PI uptake measurements 
revealed that application of BK channel inhibitors 2 μM paxilline 
(NS1619/Pax) or 100 nM Iberiotoxin (NS1619/IbTx) partially reversed 
neuroprotective effects of NS1619 (10 μM) . The data are expressed as the 
means ±SEM of three independent experiments; ***P<0.001 vs. glutamate 
###P<0.001 vs. NS1619 (Mann-Whitney U-test). Experimental media (Veh) 
were used as described in Methods sections (Organotypic hippocampal 
cultures and Pharmacological treatments).
Fig. 4. Effects of mitoKATP channel modulators on neuronal cell death in 
OHCs exposed to excitotoxicity. (A) Experimental protocol presenting the 
time windows of mitoKATP channel modulator application under excitotoxic 
conditions. 12 DIV PI-negative OHCs were treated with BMS191095 (30 μM) and 
5-hydroxydecanoic acid (5-HD; 500 μM) for 2 h before glutamate administration. 
(B) Statistical analysis of the effects of mitoKATP channel modulators on neuronal 
viability in OHCs exposed to glutamate. PI uptake measurements revealed that 
the mitoKATP channel activator BMS1910195 (30 μM) protected neurons against 
glutamate excitotoxicity. This effect was reversed by the mitoKATP channel 
inhibitor 5-hydroxydecanoic acid (5-HD; 500 μM). The data are expressed as the 
means ±SEM of three independent experiments; ***P<0.0001 vs. glutamate 
###P<0.0001 vs. BMS191095 (Mann-Whitney U-test). Experimental media 
(Veh) were used as described in Methods sections (Organotypic hippocampal 
cultures and Pharmacological treatments).
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Immunohistochemical identification of the BKCa 
channel β4 subunit in the rat hippocampus
To determine the distribution of the BKCa channel in the 
rat hippocampus, we performed double-labeling of paraffin-
embedded rat brain sections with antibodies against the 
β4 subunit of BKCa channel and microtubule-associated protein 
2 (MAP-2) as a neuronal marker. As shown in Fig. 5, we observed 
granular labeling of BKCa β4 (Fig. 5A) that closely overlapped with 
MAP-2 staining (Fig. 5B) in CA3 region of rat hippocampus. Such 
a pattern was also detected in the main hippocampal cell layers, 
including the pyramidal cell layer of CA1–CA3 fields as well as 
the dentate gyrus granule cell layer (data not shown). Analysis 
of the subcellular localization of BKCa β4 in neurons revealed 
that β4-immunoreactive clusters were localized to cytochrome 
c oxidase-positive mitochondria (Piwonska et al. 2008).
Effects of BKCa channel modulators on the 
respiration rate of isolated brain mitochondria
We next analyzed the effects of the BKCa channel 
activator on mitochondrial respiration in the presence of 
glutamate and malate as respiratory substrates. As shown 
in the representative traces in Fig. 6A, application of 10 μM 
NS1619 to a suspension of isolated mitochondria resulted 
in increased oxygen consumption (oxygen concentration), 
and an almost 100% increase in the rate of respiration (rate 
of respiration). The addition of 2 mM ADP induced further 
stimulation of respiratory chain until the maximal state 
3 respiration was reached (Fig. 6A; rate of respiration). 
Statistical analysis of results obtained in four independent 
experiments confirmed our observations and revealed that 
10 μM NS1619 increased state 2 respiration by 102.4±5% 
over the control (Fig. 6B).
Fig. 5. Immunofluorescent detection of the BKCa β4 subunit in the rat 
hippocampus. (A) Localization of the BKCa β4 subunit in the rat hippocampal 
CA3 region. The majority of BKCa β4 subunit immunoreactivity (red) was 
localized in MAP-2-positive neurons (blue) – see below. (B) Localization of the 
microtubule-associated protein 2 (MAP-2). Microtubule-associated protein 2 
(MAP-2) was used as a neuronal marker. Immunostainig was performed as 
described in Methods section (see Immunostaining of rat brain sections).
Fig. 6. Effects of BKCa channel modulators on respiration rate of 
isolated brain mitochondria. (A) Representative traces presenting the 
effects of NS1619 on oxygen consumption and respiratory rates of 
isolated brain mitochondria. The application of NS1619 (10 μM) to a 
suspension of rat brain mitochondria increased oxygen consumption 
and stimulation of respiratory chain. Additions: NS1619 10 μM; ADP 
2 mM. (B) Statistical analysis of the changes in state 2 respiration 
induced by NS1619 (10 μM) and ADP (2 mM). The data are expressed 
as the means ±SEM of four independent experiments; ***P<0.0001 
vs. control; the respiratory rate in the control was set as 100 % 
and reached a value of approximately 21.4±2 nmol O2/min/mg of 
protein. (C) Effects of Iberiotoxin on NS1619-induced stimulation of 
mitochondrial respiration. Measurements of respiratory rate were 
made in potassium medium in the presence of NS1619 alone (2–6 μM) 
(circles) or NS1619 (2–6 μM) in combination with Iberiotoxin (IbTx; 200 
nM) (triangles). Statistical analysis revealed that the NS1619-induced 
increase in respiration rate was partially reversed by IbTx. The data 
are expressed as the mean ±SEM of four independent experiments; 
the respiratory rate in the control was set as 100 % and reached a 
value of approximately 20.9±1 nmol O2/min/mg of protein.
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To test whether the stimulation of the respiratory 
chain by NS1619 was due to mitoBKCa activation, we 
analyzed the effects of this compound in the presence 
of the BKCa channel inhibitor Iberiotoxin. As shown 
in Fig. 6C, NS1619 accelerated the rate of respiration 
in a concentration-dependent manner (circles), and 
these effects were partially reversed by 200 nM IbTx 
(triangles). The addition of three subsequent aliquots 
of 2 μM NS1619 increased state 2 respiration by 35.3±2% 
(2 μM NS1619), 59.2±3% (4 μM NS1619) and 76.8±4% (6 μM 
NS1619) over the control (Fig. 6C, circles). The effectiveness 
of NS1619 was significantly reduced in the presence of the 
BKCa channel inhibitor IbTx. As presented in Fig. 6C, co-
application of NS1619 with IbTx resulted in the following 
increases of respiratory rate over the control: 13.6% for 
2 μM NS1619, 28.4±2% for 4 μM NS1619 and 39.8±3% for 
6 μM NS1619 (Fig. 6C, triangles).
Single-channel recordings of the mitoBKCa channel
To further address the presence of functional mitoBKCa 
channels in rat hippocampal mitochondria, we performed 
patch-clamp experiments on mitoplasts isolated from 
embryonic hippocampal neurons. Electrophysiological 
studies revealed the existence of single-channel 
currents (n=12) similar to those of the mitoBKCa channel 
previously reported in glioma, cardiac and brain 
mitochondria. Single-channel recordings obtained at 
different voltages in isotonic solution are presented in 
Fig. 7A. The channel conductance, calculated based on 
current-voltage relationships, was equal to 289±3 pS. 
Statistical analysis of the open probability distribution 
as well as the mean time of channel opening and closure 
revealed an apparent dependence on holding potential 
(Fig. 7B). We observed a voltage-dependent increase 
in the open probability from about 0.09 at −60 mV to 
0.95 at +10 mV. Further shifts to positive potentials 
up to +60 mV did not significantly affect the activity 
of the channel. Moreover, the mean time of channel 
opening was low at negative voltages and increased with 
increasing holding potentials (Fig. 7B; middle panel). As 
shown in Fig. 7B (right panel), the longest closed states 
of the channel were recorded at negative potentials. The 
shift to positive voltages led to decreases in the mean 
time of closure (Fig. 7B, right panel).
To gain further insight into the properties of the 
analyzed current, we applied substances known to 
modulate the activity of the mitoBKCa channel. Single-
channel recordings performed under control and low-
calcium conditions revealed the dependence of the 
channel activity on calcium concentration (Fig. 7C; 
upper trace). As shown in Fig. 7C (upper trace), after 
exchanging the control medium for a solution containing 
1 µM Ca2+, a significant decrease in channel activity was 
observed. Moreover, we demonstrated that the single-
channel current recorded under control conditions was 
sensitive to paxilline, a potent inhibitor of the large-
conductance calcium-activated potassium channel 
(Fig. 7C; lower trace). The application of paxilline to the 
pipette control solution led to irreversible inhibition of 
the channel activity.
Fig. 7. Electrophysiological identification of the BKCa channel in 
mitoplasts isolated from embryonic hippocampal neurons. (A) Single 
channel recordings at different voltages (left panel) and current-voltage 
characteristics of single-channel events (right panel) in isotonic solution. 
The holding potential is indicated to the right. Dash (–) indicates the 
closed state of the channel. Recordings were low-pass filtered at 1 kHz. (B) 
Kinetic analysis of mitoBKCa channel activity recorded at different voltages. 
Electrophysiological studies revealed voltage dependence of the open 
probability (left panel), as well as of the mean time of opening (middle 
panel) and closure (right panel). Data were taken from single channel 
recordings in isotonic solution. (C) Effect of low calcium and paxilline on 
the activity of the mitoBKCa channel. Upper panel shows the dependence 
of channel activity on calcium concentration. Single-channel currents were 
recorded in isotonic solution (control) and under low-calcium conditions 
(low calcium). Lower panel demonstrates the sensitivity of single-channel 
currents to paxilline. Single-channel recordings of a large-conductance 
potassium channel in isotonic solution (control) and after addition of 
10 mM paxilline. The holding potential is indicated to the right. Dash 
(–) indicates the closed state of the channel. Recordings were low-pass 
filtered at 1 kHz.
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Taken together, our data indicate that the observed 
single channel activity is similar to that of the mitoBKCa 
channel previously reported in glioma, cardiac, skeletal 
muscle and endothelium mitochondria (Siemen et al. 1999, 
Xu et al. 2002, Skalska et al. 2009, Bednarczyk et al. 2013a).
DISCUSSION
The role of mitochondrial potassium influx in 
neuroprotection was extensively studied after the beneficial 
effects of selective mitoKATP channel activation were 
demonstrated. In view of recent data showing the presence 
of BKCa channel in neuronal mitochondria, we hypothesized 
that pharmacological preconditioning using BKCa channel 
openers could serve as an alternative neuroprotective 
approach (Piwonska et al. 2008, Skalska et al. 2009). Thus, in 
the current study we investigated the effects of BKCa channel 
modulators on the viability of hippocampal neurons under 
excitotoxic conditions (Fig. 8). Our findings demonstrated 
that the BKCa channel opener NS1619 effectively decreased 
neuronal cell death induced by glutamate. Moreover, 
the role of BKCa channel activation in the mechanism of 
neuroprotection was confirmed by the inhibitory effect of 
the BKCa channel blockers Pax and IbTx. It remains unclear 
whether the mitochondrial or the plasma membrane 
BKCa channel is the major mediator of pharmacological 
preconditioning. Both blockers are affect mitochondrial 
channel activity (Bednarczyk et al. 2013a, 2013b), but 
organotipic hippocampal slice culture (applied in this 
manuscript) may differentiate access of these modulators to 
plasma membrane or mitochondrial BKCa channels.
There are several reports demonstrating that 
activation of plasma membrane K+ channels contribute to 
preconditioning. Application of the BKCa channel opener 
BMS204352 provided significant levels of neuroprotection 
in stroke and traumatic brain injury models (Gribkoff et 
al. 2001, Cheney et al. 2001). However, these effects are 
typically ascribed to the post-injury action of BMS204352. 
It has been proposed that potentiation of BKCa channels 
due to increased K+ efflux leads to plasma membrane 
hyperpolarization, thereby decreasing neuronal 
excitability. This supports the idea that increased open 
probability of the plasma membrane BKCa channel is 
particularly important during disturbances of energy 
homeostasis such as hypoxia or ischemia.
In contrast to these results, we found in the current study 
that neuroprotection induced by NS1619 was observed its 
presence of this drug in the medium only during preincubation 
phase. This likely reflects a mitochondrial-dependent 
preconditioning phenomenon, in which early activation of 
mitochondrial rather than plasma membrane potassium 
channels seems to play a crucial role. Consistent with this 
idea, a previous study performed on knockout mice lacking 
SUR1-based KATP channels demonstrated that increased K+ 
efflux across the plasma membrane is not obligatory for 
neuronal preconditioning induced by transient ischemia or 
diazoxide (Munoz et al. 2003). On the other hand, the role of 
mitoKATP channels was confirmed by data showing inhibition 
of cytoprotective effects by 5-HD, a selective mitoKATP channel 
blocker (Munoz et al. 2003). These findings were additionally 
strengthened by the observation that targeted expression of 
Kir6.2 in mitochondria confers protection against hypoxic 
stress (Ljubkovis et al. 2006). Furthermore, extensive evidence 
for neuroprotection induced by activation of mitochondrial K+ 
channels was provided by experiments that applied selective 
mitoKATP channel modulators. Consistent with these data, 
we found that preincubation of organotypic hippocampal 
slices with the mitoKATP channel opener BMS191095 led 
to cytoprotective effects similar to those obtained with 
NS1619 preconditioning. The specificity of BMS191095 action 
(Grover et al. 2001) was confirmed with 5-HD, a specific 
inhibitor of the mitoKATP channel (Hu et al. 1999). Parallel 
application of 5-HD with BMS191095 lead the total reversal 
of the neuroprotective effect induced by potassium channel 
opener of the mitoKATP channel (Fig. 4B). Since previous results 
excluded the effects of BMS191095 on neuronal membrane 
potential (Mayanagi et al. 2007, Gaspar et al. 2008b), it is 
reasonable to propose that increased mitochondrial K+ influx 
is the key determinant of neuroprotection in our experimental 
model. Despite the applied model is based on increased 
Ca2+ influx (induced by glutamate) via NMDA receptor. 
Fig. 8. Targeting of potassium channels effectors (potassium channel 
opener and blocker) described in this manuscript. It was marked: NS1619 
as an activators of mitochondrial large-conductance Ca2+-activated 
potassium channel (mitoBKCa) and plasma membrane large-conductance 
Ca2+-activated potassium channel (BKCa); IbTx (iberiotoxin) as an inhibitor 
of BKCa channel; Pax (paxilline) as an inhibitor of mitoBKCa and BKCa 
channel. Additionaly, 5-HD as an inhibitor and BMS191095 as an activator 
of mitochondrial ATP regulated potassium channel (mitoKATP) was shown.
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Cytoprotection induced by MK-801, a potent and selective 
NMDA receptor antagonist, confirms this injury pathway.
This hypothesis is in line with data showing that 
selective activation of the mitoKATP channel contributes 
to increased neuronal viability under excitotoxic 
conditions (Kis et al. 2004, Gaspar et al. 2008b). Although 
the detailed mechanism of mitochondrial-targeted 
preconditioning is still unclear, studies using BMS-191095 
have demonstrated that the signaling cascade initiated by 
mitoKATP channel opening likely involves mitochondrial 
depolarization, phosphorylation of protein kinase C 
(Kis et al. 2004) and activation of the phosphoinositide 
3-kinase pathway (Gaspar et al. 2008b). Moreover, it 
appears that preconditioning neurons with BMS-191095 
leads to a subsequent reduction of ROS generation during 
glutamate exposure (Kis et al. 2004). On the other hand, 
since the mitochondrial Ca2+ overload seems to be an early 
critical event in the mechanism of excitotoxicity (White 
and Reynolds 1996, Nieminen et al. 1996, Stout et al. 1998, 
Pivovarova et al. 2008), the role of mitochondrial K+ influx 
in the attenuation of calcium uptake cannot be excluded 
(Gaspar et al. 2008b).
However, evidence for a mitoBKCa channel-independent 
mechanism of neuronal preconditioning with NS1619 
has been provided (Gaspar et al. 2008a). Although 
NS1619 protected neurons in a concentration-dependent 
manner, co-application of BKCa channel blockers did not 
antagonize this effect. It appears, therefore, that either 
mitochondrial or plasma membrane BKCa channel opening 
was not required to initiate the cytoprotective signaling 
cascade in this experimental setting. On the other hand, 
NS1619 was found to depolarize isolated mitochondria 
and trigger increased ROS production (Gaspar et al. 2008a). 
The previous data showing nonspecific effects of high 
concentrations of NS1619 (Debska et al. 2003, Kicinska 
and Szewczyk 2004, Heinen et al. 2007a, 2007b), may also 
contribute to cell death/survival. Similar results were 
previously obtained using potassium channel openers – 
diazoxide (Nagy et al. 2004). The improvement of neuronal 
viability was attributed to the inhibitory effects of the 
mitoKATP channel opener on the respiratory chain complex 
II. In support of this hypothesis, neuroprotective effects of 
3-NPA, an inhibitor of succinate dehydrogenase, have been 
reported (Kis et al. 2003).
To support presence of mitoBKCa channel in brain 
mitochondria effects of channel modulators on respiration 
rate was measured. Results, confirms that the channel 
opener NS1619 increase the influx of potassium ions into 
mitochondria. Additionally, with the use of the patch-clamp 
technique we were able to show for the first time single 
channel activity and biophysical properties of the BKCa 
channel in hippocampal mitochondria. Taken together, our 
results suggest the putative role of the mitoBKCa channel in 
neuroprotection.
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